Skip to main content
Top
Published in: Diabetologia 9/2005

01-09-2005 | Editorial

The myth of the metabolic syndrome

Author: Edwin A. M. Gale

Published in: Diabetologia | Issue 9/2005

Login to get access

Excerpt

Once upon a time, no-one knew what diabetes was. No-one doubted that someone with typical symptoms and a very high blood glucose had the condition, but a line had to be drawn between those who had diabetes and those who did not, and no-one could agree where to draw it. The great epidemiologist Kelly West wrote to his colleagues to ask what they were doing, and it emerged that they just drew their own lines wherever they wanted [1]. The difficulty they all faced was that blood glucose, as measured within a population, forms a continuous gradient between health and disease. Any cut-off between the two will therefore be somewhat arbitrary. …
Literature
1.
go back to reference West KM (1975) Substantial differences in diagnostic criteria used by diabetic experts. Diabetes 24:641–644 West KM (1975) Substantial differences in diagnostic criteria used by diabetic experts. Diabetes 24:641–644
2.
go back to reference World Health Organization (1999) Definition, diagnosis, and classification of diabetes mellitus and its complications: report of a WHO consultation. Geneva, World Health Organization World Health Organization (1999) Definition, diagnosis, and classification of diabetes mellitus and its complications: report of a WHO consultation. Geneva, World Health Organization
3.
go back to reference American Diabetes Association (2000) Screening for type 2 diabetes. Diabetes Care 23(Suppl 1):20–23 American Diabetes Association (2000) Screening for type 2 diabetes. Diabetes Care 23(Suppl 1):20–23
4.
go back to reference Himsworth H (1936) Diabetes mellitus: a differentiation into insulin-sensitive and insulin-insensitive types. Lancet i:127–130 Himsworth H (1936) Diabetes mellitus: a differentiation into insulin-sensitive and insulin-insensitive types. Lancet i:127–130
5.
go back to reference Lister J, Nash J, Ledingham U (1951) Constitution and insulin sensitivity in diabetes mellitus. Br Med J i:376–379 Lister J, Nash J, Ledingham U (1951) Constitution and insulin sensitivity in diabetes mellitus. Br Med J i:376–379
6.
go back to reference Reaven GM (1988) Role of insulin resistance in human disease. Diabetes 37:1595–1607 Reaven GM (1988) Role of insulin resistance in human disease. Diabetes 37:1595–1607
7.
go back to reference Gale EAM (2004) The changing phenotype of the human species (affluent variety). Diabetologia 47:1339–1342 Gale EAM (2004) The changing phenotype of the human species (affluent variety). Diabetologia 47:1339–1342
9.
go back to reference Expert Panel on the Detection, Evaluation, and Treatment of High Blood Cholesterol in adults (2001) Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 285:2486–2497 Expert Panel on the Detection, Evaluation, and Treatment of High Blood Cholesterol in adults (2001) Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 285:2486–2497
10.
go back to reference International Diabetes Federation (2005) The IDF consensus worldwide definition of the metabolic syndrome. Available from http://www.idf.org last accessed June 2005 International Diabetes Federation (2005) The IDF consensus worldwide definition of the metabolic syndrome. Available from http://​www.​idf.​org last accessed June 2005
11.
go back to reference Ford ES, Abbasi F, Reaven GM (2005) Prevalence of insulin resistance and the metabolic syndrome with alternative definitions of impaired fasting glucose. Atherosclerosis 181:143–148 Ford ES, Abbasi F, Reaven GM (2005) Prevalence of insulin resistance and the metabolic syndrome with alternative definitions of impaired fasting glucose. Atherosclerosis 181:143–148
12.
go back to reference Soanes C, Stevenson A (eds) (2004) Concise Oxford English Dictionary, 11th edn. Oxford University Press, Oxford Soanes C, Stevenson A (eds) (2004) Concise Oxford English Dictionary, 11th edn. Oxford University Press, Oxford
13.
go back to reference Quetelet A (1835) Sur l’homme et le développement de ses facultés, ou Essai de physique sociale. Bachelier, Paris. (Reprinted in Elibron Classics Replica Edition) Quetelet A (1835) Sur l’homme et le développement de ses facultés, ou Essai de physique sociale. Bachelier, Paris. (Reprinted in Elibron Classics Replica Edition)
14.
go back to reference Asher R (1959) Making Sense. Lancet ii:359–365 Asher R (1959) Making Sense. Lancet ii:359–365
15.
go back to reference Reaven GM (2005) The metabolic syndrome: requiescat in pace. Clin Chem 51:930–931 Reaven GM (2005) The metabolic syndrome: requiescat in pace. Clin Chem 51:930–931
Metadata
Title
The myth of the metabolic syndrome
Author
Edwin A. M. Gale
Publication date
01-09-2005
Publisher
Springer-Verlag
Published in
Diabetologia / Issue 9/2005
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-005-1873-5

Other articles of this Issue 9/2005

Diabetologia 9/2005 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.